Printer Friendly

Browse Renal cell carcinoma topic



1-229 out of 229 article(s)
Title Author Type Date Words
Xynomic Pharma and UCSF Entered Strategic Partnership in Conducting a Phase 2/3 Trial of Abexinostat against Renal Cell Carcinoma. Clinical report May 22, 2017 550
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience. Lalani, Aly-Khan A.; Li, Haocheng; Heng, Daniel Y.C.; Wood, Lori; Kalirai, Austin; Bjarnason, Georg Report Mar 1, 2017 4489
Metastatic renal cell carcinoma of the head and neck: A case series. Lam, Herman P.; Addicks, Benjamin L.; Farmer, Roger W.; Fancy, Tanya Report Mar 1, 2017 2466
People with Advanced Renal Cell Carcinoma in Sweden, Norway, Denmark and Finland Now Able to Benefit from Kisplyx (Lenvatinib) in Combination with everolimus. Oct 17, 2016 1364
United States : First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT (sunitinib) Extended Disease Free Survival After Surgical Removal. Oct 12, 2016 506
United States : Updated results presented for the Opdivo (nivolumab) and Yervoy (ipilimumab) combination in Metastatic Renal Cell Carcinoma from phase 1 study. Oct 10, 2016 496
Renal Cell Carcinoma - Market Insights, Epidemiology and Market Forecast-2023. Oct 9, 2016 323
United States : CABOMETYXTM Tablets Approved for Advanced Renal Cell Carcinoma, available at Biologics, Inc. Oct 6, 2016 315
Eisai Enrols Patients in Global Phase III Trial to Evaluate First-line Kisplyx (lenvatinib) Plus Pembrolizumab or Everolimus Versus Sunitinib in Advanced Renal Cell Carcinoma[1]. Oct 2, 2016 1055
Eisai to Initiate Phase III Clinical Study of Anti-Cancer Agent Lenvatinib as Potential First-Line Therapy for Advanced Renal Cell Carcinoma. Sep 30, 2016 1526
Eisai Receives License for New Indication for Anticancer Agent Kisplyx (Lenvatinib Mesylate) for Treatment of Advanced Renal Cell Carcinoma. Clinical report Sep 15, 2016 1466
European Commission Grants Marketing Authorisation for Kisplyx ,u- (Lenvatinib) in Combination with Everolimus in Advanced Renal Cell Carcinoma. Sep 14, 2016 1268
Initial response of renal cell carcinoma to vemurafenib in a patient treated for metastatic melanoma. Hosier, Gregory W.; Roberts, Matthew T. Sep 1, 2016 1726
A case of renal cell carcinoma and angiomyolipoma in an adolescent girl. Rood, J.W.; Mokhobo, K.P. Clinical report Aug 1, 2016 1614
Kisplyx (lenvatinib) in Combination with everolimus Receives Positive CHMP Opinion in Advanced Renal Cell Carcinoma. Jul 22, 2016 1697
Eisai Receives Positive CHMP Opinion on New Indication for Anticancer Agent Lenvatinib in Combination with Everolimus for Treatment of Advanced Renal Cell Carcinoma. Jul 22, 2016 1275
Renal Cell Carcinoma Market Growth Steady to 2023 Says a Global EpiCast Report. Report Jun 27, 2016 1053
Renal Cell Carcinoma Market Growth Steady to 2023 Says a Global EpiCast Report. Report Jun 27, 2016 1057
Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021. Jun 16, 2016 786
What's new in renal cancer research? Kapoor, Anil Report May 1, 2016 992
Renal cell carcinoma extending to the inferior vena cava: a single center surgical experience. Sayyad, Ahmed J. Al; Algarni, Kamal S.; Jabbad, Husain H. Report May 1, 2016 2409
Diplomat to Dispense CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma. Apr 28, 2016 801
Germany,United States : Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA in Renal Cell Carcinoma. Apr 7, 2016 498
A simple prognostic model for overall survival in metastatic renal cell carcinoma. Assi, Hazem I.; Patenaude, Francois; Toumishey, Ethan; Ross, Laura; Abdelsalam, Mahmoud; Reiman, Ton Clinical report Mar 1, 2016 4738
Japan,United States : U.S. FDA accepts for priority review sNDA for EISAI's anticancer agent lenvatinib seeking approval for renal cell carcinoma. Jan 19, 2016 477
Eisai's Lenvatinib Receives FDA Priority Review for the Potential Treatment of Advanced Renal Cell Carcinoma in Combination with Everolimus. Jan 17, 2016 2061
Eisai Submits New Application in Europe for In-House Developed Anticancer Agent Lenvatinib Seeking Approval for Indication Covering Renal Cell Carcinoma. Jan 12, 2016 1223
New Application of Lenvatinib in Combination with Everolimus for Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC) Submitted to the European Medicines Agency (EMA) by Eisai. Jan 11, 2016 1563
HealthWell Foundation Opens New Medicare Access Fund to Provide Financial Assistance to Renal Cell Carcinoma Patients. Dec 30, 2015 652
Renal cell carcinoma concomitant with lumbar radiculopathy in a 75-year-old woman presenting with low back pain/75 yasindaki bir hastada bel agrisi nedeni: renal hucreli karsinom ve lomber radikulopati birlikteligi. Inal, Esra Erkol; Yener, Mahmut; Cetinturk, Azize; Inal, Salih; Kosar, Alim; Savas, Serpil Report Dec 1, 2015 1461
A single-centre experience with tumour tract seeding associated with needle manipulation of renal cell carcinomas. Viswanathan, Aravind; Ingimarsson, Johann P.; Seigne, John D.; Schned, Alan R. Case study Nov 1, 2015 1823
Japan : Phase II trial results on Novel Anticancer agent Lenvima in renal cell carcinoma published in the lancet oncology. Oct 21, 2015 454
Phase II Trial Results on Novel Anticancer Agent Lenvima in Renal Cell Carcinoma Published in the Lancet Oncology. Oct 19, 2015 1333
Results from Phase 2 Trial Investigating Lenvatinib in Metastatic Renal Cell Carcinoma Published in The Lancet Oncology. Clinical report Oct 16, 2015 2135
Lenvatinib Phase II Results Published in The Lancet Oncology Show Significant Improvement in Progression-Free Survival When Used With Everolimus in Metastatic Renal Cell Carcinoma. Oct 15, 2015 1596
Savolitinib Completes Enrolment for Phase II Clinical Trial in Papillary Renal Cell Carcinoma. Oct 13, 2015 790
Clinicohistological characteristics of renal cell carcinoma in children: a multicentre study. Kim, Jeong Ho; Seo, Seong Il; Song, Cheryn; Chung, Jinsoo; Kwak, Cheol; Hong, Sung-Hoo Report Oct 1, 2015 2850
Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: observational study of survival outcomes. Nason, Gregory J.; Walsh, Leon G.; Redmond, Ciaran E.; Kelly, Niall P.; McGuire, Barry B.; Sharma, V Report Sep 1, 2015 3206
Sorafenib treatment for recurrent stage T1 bilateral renal cell carcinoma in patients with Von Hippel- Lindau disease: a case report and literature review. Choi, Kyung Hwa; Yu, Young Dong; Kang, Moon Hyung; Park, Dong Soo Case study Sep 1, 2015 1794
Tubulocystic renal cell carcinoma: report of a rare case. Kakkar, Aanchal; Sharma, Mehar C.; Uppal, Manpreet; Chumber, Sunil Case study Sep 1, 2015 2068
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma. Iacovelli, Roberto; Santini, Daniele; Rizzo, Mimma; Felici, Alessandra; Santoni, Matteo; Verzoni, El Report Aug 1, 2015 3478
Imaging hallmark of Xp11.2 translocation renal cell carcinoma. Sureka, Binit; Bansal, Kalpana; Arora, Ankur Aug 1, 2015 383
Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: current evidence and future directions. Swaminath, Anand; Chu, William Report Aug 1, 2015 3874
Metastatic renal cell cancer: summary from ASCO 2015. Conference notes Aug 1, 2015 2447
Third-line treatment in metastatic renal cell carcinoma and bone metastases. Heng, Daniel Y.C. Viewpoint essay Aug 1, 2015 667
FDA Grants Breakthrough Therapy Designation to Eisai's Lenvatinib for the Potential Treatment of Metastatic Renal Cell Carcinoma. Jul 28, 2015 2024
Composite renal cell carcinoma and angiomyolipoma in a patient with tuberous sclerosis: a diagnostic dilemma. Kakkar, Aanchal; Vallonthaiel, Archana George; Sharma, Mehar Chand; Bora, Girdhar; Panda, Ananya; Se Clinical report Jul 1, 2015 1881
Renal vein leiomyosarcoma and renal cell carcinoma presenting together: a case report and discussion on the follow-up. Devlin, Conor M.; Gill, Kanwar; Thomas, Jennifer; Biyani, Chandra Shekhar Clinical report Jul 1, 2015 1796
Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: a systematic review and meta-analysis. Russo, Giorgio Ivan; Di Rosa, Alessandro; Favilla, Vincenzo; Fragala, Eugenia; Castelli, Tommaso; Pr Report Jun 1, 2015 6121
Lenvatinib Significantly Increases Progression Free Survival and Overall Response Rate When Used With Everolimus in Metastatic Renal Cell Carcinoma. Jun 1, 2015 2752
Results from Phase 2 Study of Lenvatinib when Combined with Everolimus in Metastatic Renal Cell Carcinoma to be Presented in Oral Session at ASCO. Jun 1, 2015 1996
PROCLAIM Patient Registry Data Demonstrate Survival Benefit of First-line Proleukin Therapy in Patients with Metastatic Renal Cell Carcinoma. May 28, 2015 1468
Angiosarcoma of the adrenal gland with concurrent contralateral advanced renal cell carcinoma: a diagnostic and management dilemma. Gusenbauer, Kaela; Ruzhynsky, Vladimir; Kak, Ipshita; Adili, Anthony F.; Giedraitis, Kyle; Popovic, Clinical report May 1, 2015 2473
Renal cell carcinoma and amyopathic dermatomyositis. Adili, Anthony F.; Liaconis, Haralambos; Gusenbauer, Kaela; Kapoor, Anil Clinical report May 1, 2015 1534
Renal cell carcinoma after neuroblastoma: a case study and review of the literature. Wallace, Brendan; Organ, Michael; Bagnell, Scott; Rendon, Ricardo; Merrimen, Jennifer Clinical report May 1, 2015 1508
Efficacy of percutaneous cryoablation of renal cell carcinoma in older patients with medical comorbidities: outcome study in 70 patients. Lang, Erich K.; Zhang, Kan Karl; Nguyen, Quan; Myers, Leann; Allaf, Mahamed; Colon, Ivan Report May 1, 2015 3995
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): case report and review of the literature. de Velasco, Guillermo; Munoz, Cesar; Sepulveda, Juan M.; Castellano, Daniel Case study Apr 1, 2015 2140
Clinical outcome and prognostic factors in renal medullary carcinoma: a pooled analysis from 18 years of medical literature. Iacovelli, Roberto; Modica, Daniela; Palazzo, Antonella; Trenta, Patrizia; Piesco, Gabriele; Cortesi Clinical report Apr 1, 2015 3378
Concurrent RCC with tuberculous para-aortic lymphadenopathy: a pleasant surprise. Pushkar, Praveen; Agarwal, Anshuman; Sarin, Ashok; Kashyap, Vikas Case study Apr 1, 2015 1072
Papillary RCC and oncocytoma: longer follow-up reported. Floyd, Michael S., Jr.; DeBoll, Alan R. Report Apr 1, 2015 931
Superior sagittal sinus thrombosis as the initial presentation of renal cell carcinoma. Reddy, Manoj P.; Gross, Lara M.; Moreland, Amber; DeMarco, Daniel C. Case study Apr 1, 2015 917
Lpath Reports Results for ASONEP Phase 2a Study in Renal Cell Carcinoma. Mar 24, 2015 1258
Eisai's Phase II Trial of Anticancer Agent Lenvatinib in Renal Cell Carcinoma Meets Primary Endpoint. Feb 2, 2015 1098
Strain elastography in the characterization of renal cell carcinoma and angiomyolipoma. Keskin, Suat; Guven, Selcuk; Keskin, Zeynep; Ozbiner, Huseyin; Kerimoglu, Ulku; Yesildag, Ahmet Report Feb 1, 2015 2686
Cystic renal neoplasms in adults: current imaging update. Katabathina, Venkata S.; Gangadhar, Kiran; Vinu-Nair, Sandhya; Prasad, Srinivasa R. Report Jan 1, 2015 3945
A rare case of spontaneous necrosis of primary renal cell carcinoma. Matsuzaki, Kyosuke; Imamura, Ryoichi; Iwanishi, Toshichika; Nakagawa, Masahiro; Tanigawa, Go; Tsutah Case study Jan 1, 2015 1207
A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma. Taskinlar, Hakan; Avlan, Dincer; Citak, Caglar; Polat, Ayse; Nayci, Ali Case study Jan 1, 2015 2177
Eosinophilic variant of chromophobe renal cell carcinoma. Podduturi, Varsha; Yourshaw, Charles J., III; Zhang, Haiying Case study Dec 26, 2014 1120
Papillary renal cell carcinoma within a renal oncocytoma: case report of very rare coexistence. Ozer, Cevahir; Goren, Mehmet Resit; Egilmez, Tulga; Bal, Nebil Case study Dec 1, 2014 1421
Metastatic renal cell carcinoma to the testis: a case report and review of the literature. Marzouk, Karim; Alyami, Fahad; Merrimen, Jennifer; Bagnell, Scott Case study Dec 1, 2014 1975
Laparoscopic partial nephrectomy for renal cell carcinoma in a horseshoe kidney. Benidir, Tarik; de Castilho, Tiago Jacometo Coelho; Cherubini, Guilherme Rodrigo Lobo; de Almeida Lu Case study Dec 1, 2014 1640
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. Richter, Suzanne; Seah, Jo-An; Pond, Gregory R.; Gan, Hui K.; Mackenzie, Mary J.; Hotte, Sebastien J Report Dec 1, 2014 3357
Hypernephroma. Azouka, Imad Clinical report Nov 1, 2014 457
Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma. Zhao, Juping; Huang, Xin; Sun, Fukang; Ma, Renyi; Wang, Haofei; Shao, Kun; Zhu, Yu; Zhou, Wenlong; X Report Nov 1, 2014 4856
Investigation of VEGF-C involvement in acquired metastatic properties of renal cell carcinoma following anti-angiogenesis treatments. Oct 31, 2014 317
Despite Generic Erosion of Several Key Brands, the Renal Cell Carcinoma (RCC) Market Will Experience Modest Growth through 2023. Oct 16, 2014 636
Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma. Butz, Henriett; Szabo, Peter M.; Nofech-Mozes, Roy; Rotondo, Fabio; Kovacs, Kalman; Mirham, Lorna; G Report Oct 1, 2014 6056
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023. Report Sep 2, 2014 1234
Fine needle aspiration cytology of chromophobe renal cell carcinoma. A report of two cases. Naran, Sarla; Lallu, Sharda; Bethwaite, Peter Clinical report Aug 1, 2014 2063
Does gender influence morbidity or mortality in the surgical treatment of renal masses? Minnillo, Brian J.; Horowitz, Andrew; Finelli, Antonio; Alibhai, Shabbir M.H.; Ponsky, Lee E.; Aboua Report May 1, 2014 3374
United Kingdom : Results from phase III patient preference study of GSK s Votrient (pazopanib) vs. Sutent (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology. Clinical report Apr 2, 2014 144
Fine needle aspiration of a translocation/ TFE3 fusion renal cell carcinoma metastatic to the liver: a case report. Lallu, Sharda; Naran, Sarla; Bethwaite, Peter; Kenwright, Diane Clinical report Apr 1, 2014 1915
For Drugs Targeting Colorectal Cancer and Renal Cell Carcinoma, Managed Care Strategies Shift the Payment Dynamics for Physicians and Create New Challenges. Mar 4, 2014 664
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib. Iacovelli, Roberto; Cartenì, Giacomo; Milella, Michele; Berardi, Rossana; Di Lorenzo, Giusep Report Mar 1, 2014 3029
Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia. Park, Dong Soo; Hwang, Jin Ho; Kang, Moon Hyung; Oh, Jong Jin Report Mar 1, 2014 3554
Collecting duct of Bellini renal carcinoma with psoas muscle recurrence: A case report and review of literature. Chua, Michael Erlano; Olondriz, Karen; Maniwa, Michael; Mendoza, Jonathan; Castillo, Josefino Clinical report Mar 1, 2014 2239
Ovarian metastasis of clear cell renal cell carcinoma: A case report. Bauerova, Lenka; Dundr, Pavel; Fischerova, Daniela; Pešl, Michael; Zikan, Michal; Burgetova, Clinical report Mar 1, 2014 2828
Clinico-pathological analysis of renal cell carcinoma demonstrates decreasing tumour grade over a 17-year period. Nason, Gregory J.; McGuire, Barry B.; Kelly, Michael E.; Murphy, Theodore M.; Looney, Aisling T.; By Report Mar 1, 2014 3357
Solidifying prognosis after surgery for renal cell carcinoma. Leveridge, Michael J. Mar 1, 2014 987
What's new in renal cell cancer research? Highlights of GU-ASCO 2014. Kapoor, Anil Conference notes Mar 1, 2014 1707
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. Organ, Michael; Jewett, Michael; Basiuk, Joan; Morash, Christopher; Pautler, Stephen; Siemens, D. Ro Clinical report Jan 1, 2014 3008
Handling patients with growing small renal masses. Russo, Paul Clinical report Jan 1, 2014 855
The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma. Hakimi, A. Ari; Chen, Ling; Kim, Philip H.; Sjoberg, Daniel; Glickman, Leonard; Walker, Marc R.; Rus Clinical report Nov 1, 2013 3682
Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat. Mehta, Vikas; Mudaliar, Kumaran; Ghai, Ritu; Quek, Marcus L.; Milner, John; Flanigan, Robert C.; Pic Report Nov 1, 2013 5175
Enhancer of Zeste Homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature. Xu, Bin; Abourbih, Samuel; Sircar, Kanishka; Kassouf, Wassim; Mansure, Jose Joao; Aprikian, Armen; T Report Oct 1, 2013 9949
Combinability of CRLX101 and Avastin Established in Clinical Trial in Renal Cell Carcinoma. Sep 26, 2013 841
Spontaneous regression of metastatic pulmonary renal cell carcinoma in the setting of sarcomatoid differentiation of the primary tumour. Chan, Brian P.H.; Booth, Christopher M.; Manduch, Marosh; Touma, Naji J. Case study Sep 1, 2013 1812
Lymphoepithelioma-like carcinoma of the renal pelvis: Pathological and therapeutic implications. Modi, Hemel; Beckley, Ian; Bhattarai, Selina; Spencer, John; Cartledge, Jon Case study Sep 1, 2013 2484
Double jeopardy? Renal-sparing management of simultaneous ipsilateral renal cell carcinoma and urothelial carcinoma. Bay, Benjamin N.; Black, Peter Jul 1, 2013 1842
Papillary renal cell carcinoma embedded in an oncocytoma: case report of a rare combined tumour of the kidney. Sejben, Istvan; Szabo, Zoltan; Lukacs, Nandor; Lorand, Marta; Sukosd, Farkas; Cserni, Gabor Jul 1, 2013 2512
Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report. Morita, Jun; Naoe, Michio; Ogawa, Yu; Nakasato, Takehiko; Sugahara, Motoko; Morita, Masashi; Fuji, K Clinical report May 1, 2013 2385
Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Goyal, Rajen; Gersbach, Elizabeth; Yang, Ximing J.; Rohan, Stephen M. Report Apr 1, 2013 11645
Treating small renal masses: Costing it out. Yap, Stanley A.; Finelli, Antonio; Alibhai, Shabbir M.H. Report Apr 1, 2013 1298
In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders' Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies. Mar 26, 2013 567
Renal cell carcinoma seeding of a percutaneous biopsy tract. Mullins, Jeffrey K.; Rodriguez, Ronald Clinical report Mar 1, 2013 2584
AVEO and Astellas Announce FDA Advisory Committee To Review Tivozanib for the Treatment of Advanced Renal Cell Carcinoma. Feb 27, 2013 1293
Acceleron Initiates Phase 2 Study of Dalantercept (ACE-041) to Treat Patients with Metastatic Renal Cell Carcinoma. Feb 5, 2013 724
Low-grade clear cell renal cell carcinoma mimicking hemangioma of the kidney: a series of 4 cases. Kryvenko, Oleksandr N.; Roquero, Leonardo; Gupta, Nilesh S.; Lee, Min W.; Epstein, Jonathan I. Report Feb 1, 2013 2612
Research and Markets: IMA901 (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 for US, EU5 and Japan. Jan 16, 2013 269
Research and Markets: Votrient (Renal Cell Carcinoma) - Analysis and Forecasts to 2022. Jan 8, 2013 377
Research and Markets: Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2022. Jan 7, 2013 320
Early immune outcome of retroperitoneal laparoscopic radical nephrectomy for localized renal cell carcinoma: a prospective, randomized study. Lu, Yang; Tianyong, Fan; Qiang, Wei; Xiaobo, Cui; Siyuan, Bu; Ping, Han Report Dec 1, 2012 4427
AVEO and Astellas Announce FDA Acceptance of NDA Filing for Tivozanib for the Treatment of Advanced Renal Cell Carcinoma. Nov 28, 2012 1283
Through 2021, Small-Molecule Angiogenesis Inhibitors Will Dominate the Renal Cell Carcinoma Treatment Landscape and the Market Share for this Drug Class Will Peak in 2017 at Nearly 85 Percent. Nov 26, 2012 862
Research and Markets: Global Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2012. Clinical report Nov 9, 2012 322
Research and Markets: Renal Cell Carcinoma - Pipeline Review, H2 2012. Nov 2, 2012 376
Renal cell carcinoma metastatic to the sinonasal region: three case reports with a review of the literature. Parida, Pradipta Kumar Brief article Nov 1, 2012 123
Pfizer Announces Top-line Results From Phase 3 Trial Of INLYTA[R] (axitinib) In Treatment-Naove Patients With Advanced Renal Cell Carcinoma. Oct 17, 2012 1464
Research and Markets: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2012. Oct 8, 2012 410
Spontaneous regression of biopsy proven primary renal cell carcinoma: A case study. Jawanda, Gurswinder Gary; Drachenberg, Darrel Case study Oct 1, 2012 2066
Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy. Demir, Lutfiye; Erten, Cigdem; Somali, Isil; Can, Alper; Dirican, Ahmet; Bayoglu, Vedat; Kucukzeybek Case study Oct 1, 2012 2231
AVEO and Astellas Announce Submission of New Drug Application for Tivozanib for the Treatment of Advanced Renal Cell Carcinoma. Sep 28, 2012 1204
Research and Markets: Nexavar (Renal Cell Carcinoma) - Analysis and Forecasts to 2022. Sep 11, 2012 384
United States : EUROPE approves Inlyta for ADVANCED RENAL CELL CARCINOMA. Sep 5, 2012 179
Seattle Genetics Announces Initiation of a Phase Ib Trial of SGN-75 in Combination with Everolimus for Patients with Renal Cell Carcinoma. Aug 24, 2012 851
Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC). Aug 10, 2012 1283
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma. Jun 2, 2012 1601
Pfizer Provides Topline Results From Phase 3 Study Of Torisel[R] As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC). Report May 15, 2012 2140
Predictors of response to targeted therapy in renal cell carcinoma. Eisengart, Laurie J.; MacVicar, Gary R.; Yang, Ximing J. May 1, 2012 6213
Acceleron's ACE-041 Combined with a VEGF Inhibitor Shows Potent Activity in Preclinical Model of VEGF-Resistant Renal Cell Carcinoma. Apr 3, 2012 661
Partial Nephrectomy for T1b Renal Cell Carcinoma: A Safe and Superior Treatment Option. Mason, Ross J.; Rendon, Ricardo A. Report Apr 1, 2012 2608
Partial nephrectomy is not the proven standard for Stage T1b renal cell carcinoma. Finelli, Tony Apr 1, 2012 2477
Occult infiltrating bi-ventricular papillary renal cell carcinoma metastasis found during coronary artery bypass graft surgery. Mollberg, Nathan M.; Johnson, Nicholas B.; Ying, Shan-Chinga; Abdelhady, Khaled; Massad, Malek G.; C Clinical report Apr 1, 2012 1712
Renal cell carcinoma with secondary hemophagocytic syndrome: A case report. Chao, Chia-Ter; Kao, Chih-Chin; Lee, Szu-Ying; Ho, Shu-Jung; Jhuang, Ying-Jheng; Li, Lars Hung-Yuan; Clinical report Apr 1, 2012 1881
Renal hucreli karsinomda karbonik anhidraz 9 ve HIF-l[alpha]'nin prognostik degeri / Prognostic value of carbonic anhydrase IX and HIF-l[alpha] in renal cell carcinoma. Gunaydin, Bilal; Yilaorim, Asif; Zemberi, Ebru; Ozkanli, Seyma; Gocerl, Serhat; Keskin, Sarp Korcan; Report Mar 1, 2012 4449
Argos Therapeutic Arcelis[TM] Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC). Jan 31, 2012 738
SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma. Jan 9, 2012 604
SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma. Jan 9, 2012 609
The Renal Cell Carcinoma Drug Market Will Experience Robust 3.7 Percent Annual Growth from 2010 to 2020. Dec 8, 2011 807
FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In Previously Treated Advanced Renal Cell Carcinoma (RCC) To Be Favorable. Dec 7, 2011 664
FDA gives Pfizer approval to proceed developing Axitinib for advanced renal cell carcinoma. Dec 1, 2011 191
Intrahepatic extension of renal cell carcinoma tumor thrombus causing Budd-Chiari syndrome. Lessard, Lauren; Bach, David; Wall, William; Luke, Patrick P.W. Case study Dec 1, 2011 484
Pathological features of incidental and symptomatic renal cell carcinoma / Rastlantisal ve semptomatik bobrek hucreli karsinomlarin patolojik ozellikleri. Bayraktar, Zeki; Atun, Ihsan Report Dec 1, 2011 3756
Potential anti-cancer therapy deprives cancer cells of glucose. McBride, Deborah Brief article Oct 1, 2011 261
In the United States, Nearly All Surveyed Physicians Prescribe Pfizer's Sutent and a Significant Majority Prescribe Bayer/Onyx's Nexavar for the Treatment of Renal Cell Carcinoma. Aug 2, 2011 550
Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications. Pinthus, Jehonathan H.; Whelan, Kaitlyn F.; Gallino, Daniel; Lu, Jian-Ping; Rothschild, Nathan Report Aug 1, 2011 7422
Pfizer Files With The FDA For Review Of Axitinib For Patients With Advanced Renal Cell Carcinoma. Jun 28, 2011 811
First Patients are Vaccinated in IMPRINT*, immatics' Pivotal Phase III Trial With IMA901 in Patients With Renal Cell Carcinoma (RCC). Jun 15, 2011 890
Pfizer Files For European Regulatory Review Of Axitinib For Patients With Advanced Renal Cell Carcinoma. Jun 1, 2011 813
Tyrosine kinase inhibitors for the treatment of metastatic renal cell carcinoma: what urologists should know? / Metastatik renal hucreli karsinom tedavisinde tirozin kinaz inhibitorleri: Urologlar ne bilmelidir? Kotb, Ahmed Fouad Jun 1, 2011 5255
Omental cake formation in renal cell carcinoma: A case report and review of the literature / Bobrek hucreli kanserde "omental cake" olusumu: Olgu sunumu ve literaturun gozden gecirilmesi. Kuzgunbay, Baris; Goren, Mehmet Resit; Guvel Sezgin Jun 1, 2011 914
Research and Markets: Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy. May 31, 2011 282
Pfizer Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma. May 18, 2011 1938
Subclavian vein thrombosis: an unusual presentation of renal cell carcinoma. Hameed, Ammar; Pahuja, Ajay; Thwaini, Ali; Nambirajan, Thiagarajan Case study Apr 1, 2011 1083
Caution in metastatic renal cell carcinoma within lymph nodes: PAX-2 expression is also seen in nodal lymphocytes. Gilmore, Lauren; Dewar, Rajan Letter to the editor Apr 1, 2011 891
Multilocular cystic renal cell carcinoma: a case report of a rare entity. Agarwal, Shweta; Agrawal, Usha; Mohanty, N.K.; Saxena, Sunita Letter to the editor Mar 1, 2011 926
How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes? Martínez, Carlos H; Martin, Paul; Chalasani, Venu; Williams, Andrew K.; Luke, Patrick P. W.; Report Mar 1, 2011 2179
Iki tarafli surrenal metastazli renal hucreli karsinom olgusu / A renal cell carcinoma case presenting with bilateral adrenal metastasis. Karadag, Demet; Caglar, Oya Mar 1, 2011 1655
Research and Markets: Renal Cell Carcinoma (RCC) Therapeutics - Pipeline Assessment and Market Forecasts to 2017. Feb 18, 2011 555
For the Treatment of Advanced Renal Cell Carcinoma, the Highest Proportion of Surveyed MCOs Select Pfizer's Sutent as the Most Efficacious and the Safest and Most Tolerable Agent. Jan 12, 2011 562
Bilateral renal sinus myelolipomas. Cox, Ashley; Offman, Saul L.; Merrimen, Jennifer L.O.; Kew, Andrea; Norman, Richard W. Case study Dec 1, 2010 1836
Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes. Chalasani, Venu; Martinez, Carlos H.; Lim, Darwin; Abdelhady, Mazen; Chin, Joseph L. Report Dec 1, 2010 2626
Tumour location as a predictor of benign disease in the management of renal masses. Mason, Ross J.; Abdolell, Mohamed; Rendon, Ricardo A. Report Dec 1, 2010 2672
Can tumour location predict degree of malignancy in small renal masses? Jewett, Michael A. S. Dec 1, 2010 596
Impact of renal capsular infiltration on disease specific survival in patients with localized renal cell carcinoma ([less than or equal to]pT2) / Lokalize renal hucreli kanserlerde (pT[less than or equal to]2) renal kapsul infiltrasyonunun hastalik spesifik sagkalim uzerine etkisi. Oztekin, Cetin Volkan; Akdemir, Alp Ozgur; Doluoglu, Omer Gokhan; Ugurlu, Ozgur; Sungur, Mustafa; Ce Report Dec 1, 2010 2922
Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC). Nov 19, 2010 1799
Research and Markets: Renal Cell Carcinoma Cancer Drug Futures 2010. Nov 15, 2010 499
Cost analysis of two follow-up strategies for localized kidney cancer: a Canadian cohort comparison. Dion, Marie; Martínez, Carlos H.; Williams, Andrew K.; Chalasani, Venu; Nott, Linda; Pautler Report Oct 1, 2010 2792
Residual renal function after partial or radical nephrectomy for renal cell carcinoma. Chapman, David; Moore, Ron; Klarenbach, Scott; Braam, Branko Clinical report Oct 1, 2010 5819
Use of a novel parenchymal clamp for laparoscopic and open partial nephrectomy. Toren, Paul; Al-Essawi, Turki; Mclean, Anthony; Jain, Umesh Case study Oct 1, 2010 2142
AVEO Achieves Enrollment Target Ahead of Schedule for Pivotal Phase 3 Trial of Tivozanib in Patients with Advanced Renal Cell Carcinoma. Aug 12, 2010 1404
Antegrade balloon occlusion of inferior vena cava duringd thrombectomy for renal cell carcinoma. Metcalfe, Charles; Chang-Kit, Laura; Dumitru, Ioana; MacDonald, Shaun; Black, Peter Case study Aug 1, 2010 2498
PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin. Ozcan, Ayhan; Zhai, Qihui; Javed, Rehana; Shen, Steven S.; Coffey, Donna; Krishnan, Bhuvaneswari; Tr Aug 1, 2010 5492
Solid variant of papillary renal cell carcinoma with spindle cell and tubular components. Cantley, Richard; Gattuso, Paolo; Cimbaluk, David Aug 1, 2010 3047
Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Fang, Xueping; Gupta, Nilesh; Shen, Steven S.; Tamboli, Pheroze; Charnsangavej, Chusilp; Rashid, Asi Jul 1, 2010 4238
Robust Annual Growth in the Renal Cell Carcinoma Drug Market Will be Driven by the Uptake of GlaxoSmithKline's Votrient/Patorma and the Launches of Premium-Priced Emerging Therapies. Jun 29, 2010 604
AVEO Pharmaceuticals, Inc. Receives Orphan Medicinal Product Designation for Tivozanib for the Treatment of Renal Cell Carcinoma by the European Medicines Agency. Jun 24, 2010 1261
Metastatic renal cell carcinoma with metabolic syndrome- a case report. Kelly, Kemper; Cocklin, Carrie Case study Jun 22, 2010 2877
Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review. Canil, Christina; Hotte, Sebastien; Mayhew, Linda A.; Waldron, Tricia S.; Winquist, Eric Clinical report Jun 1, 2010 4264
Renal cell carcinoma presenting as an ominous metachronous scalp metastasis. Smyth, Lisa G.; Casey, Rowan G.; Quinlan, David M. Case study Jun 1, 2010 2056
Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Srigley, John R.; Amin, Mahul B.; Delahunt, Brett; Campbell, Steven C.; Chang, Anthony; Grignon, Dav Apr 1, 2010 3764
Recurrent renal cell cancer: 10 years or more after nephrectomy. Abara, Emmanuel; Chivulescu, Iolanda; Clerk, Nilam; Cano, Pablo; Goth, Alexis Case study Apr 1, 2010 3169
Active surveillance as the preferred management option for small renal masses. Rendon, Ricardo A. Report Apr 1, 2010 2338
Nephrectomy is necessary in the treatment of metastatic renal cell carcinoma. Youssif, Tamer Abou; Tanguay, Simon Report Feb 1, 2010 1857
Cytoreductive nephrectomy: a treatment of the past. Venner, Peter Report Feb 1, 2010 1748
Xp11.2 translocation renal cell carcinoma. Armah, Henry B.; Parwani, Anil V. Report Jan 1, 2010 4453
Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker. Dancer, Jane Y.; Truong, Luan D.; Zhai, Qihui; Shen, Steven S. Clinical report Jan 1, 2010 3269
Significance of ultrasonography in detection of incidental renal cell carcinoma/Rastlantisal bobrek hucreli karsinomlarin tespitinde ultrasonografinin onemi. Bayraktar, Zeki; Atun, Ihsan; Dama, Neriman Report Dec 1, 2009 2661
Sarcomatoid chromophobe renal cell carcinoma with heterologous sarcomatoid elements: a case report and review of the literature. Quiroga-Garza, Gabriela; Khurana, Hema; Shen, Steven; Ayala, Alberto G.; Ro, Jae Y. Clinical report Nov 1, 2009 2156
Toothache as a presenting symptom of metastatic renal cell cancer. Hallock, Abhirami; Rodrigues, George Case study Oct 1, 2009 1492
Renal cell carcinoma with caval thrombus extending to the right atrium in a horseshoe kidney: a unique surgical challenge. Greene, Graham F.; Bissada, Nabil K.; Madi, Rabii Case study Oct 1, 2009 1317
Idera Pharmaceuticals Presents Final Data from Phase 2 Clinical Trial of IMO-2055 Monotherapy in Renal Cell Carcinoma. Sep 25, 2009 1150
Obesity, body composition, and risk of renal cell cancer: a population-based case-control study. Asal, Nabih R.; Theis, Ryan P.; Grieb, Suzanne M. Dolwick; Burr, Deborah; Benardot, Dan; Siddiqui, T Report Jan 1, 2009 7929
Argos Therapeutics Initiates Phase 2 Trial in Renal Cell Carcinoma for its Arcelis(TM) Personalized Immunotherapy Platform. Sep 10, 2008 642
AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients with Metastatic Renal Cell Carcinoma. May 29, 2008 557
Metastasectomy lowers risk of renal cancer recurrence. Boschert, Sherry May 1, 2008 729
Sequence of Treatments May Induce Clinical Response in Metastatic Renal Cell Carcinoma Patients. Mar 13, 2008 578
Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis. Sarkissian, Gaiane; Fergelot, Patricia; Lamy, Pierre-Jean; Patard, Jean-Jacques; Culine, Stephane; J Mar 1, 2008 5208
AVEO Initiates Phase 1b Combination Clinical Trial of Novel Triple VEGF Receptor Inhibitor AV-951 in Metastatic Renal Cell Carcinoma. Jan 31, 2008 699
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma. Sep 20, 2007 2125
HT boosts renal cancer risk in obese patients. Evans, Jeff Sep 15, 2007 346
Understand Why Only 25% Of The Global Renal Cell Carcinoma Market Is In Europe. Sep 12, 2007 355
HIV-associated renal cell cancer. Hulbert, F.; Ozzard. A.; Tuthill, Bower, Mark Case study Sep 1, 2007 1467
Metastatic renal cell carcinoma. Brief article Sep 1, 2007 82
Bevacizumab aids survival of renal cancer patients: combination regimen may improve safety. Wendling, Patrice Clinical report Jul 1, 2007 743
Targeted therapy for renal cell carcinoma: a new treatment paradigm. Hutson, Thomas E. Clinical report Jul 1, 2007 4954
Rexahn Pharmaceuticals Receives FDA Approval to Initiate a Phase II Trial for Archexin in Patients with Renal Cell Carcinoma. May 29, 2007 705
Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease. Polydorides, Alexandros D.; Rosenblum, Marc K.; Edgar, Mark A. Clinical report Apr 1, 2007 4010
Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Brownlee, Noel A.; Perkins, L. Allen; Stewart, Will; Jackle, Beth; Pettenati, Mark J.; Koty, Patrick Clinical report Mar 1, 2007 3662
Prognostic significance of CD44, platelet-derived growth factor receptor [alpha], and cyclooxygenase 2 expression in renal cell carcinoma. Tawfik, Ossama W.; Kramer, Brandan; Shideler, Barbara; Danley, Marsha; Kimler, Bruce F.; Holzbeierle Clinical report Feb 1, 2007 4784
RF ablation useful for small renal cell cancers. Jancin, Bruce Jan 15, 2007 480
Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Leroy, Xavier; Zini, Laurent; Buob, David; Ballereau, Charles; Villers, Arnauld; Aubert, Sebastien Clinical report Jan 1, 2007 3611
Sunitinib superior to interferon-[alpha] for advanced renal cell carcinoma. Lowry, Fran Oct 15, 2006 412
Renal cell carcinoma: diagnosis and treatment, 1994-2003. Hutson, Thomas E. Clinical report Oct 1, 2005 2536
Wyeth gains "fast-track" designation from FDA for drug to treat advanced renal cell carcinoma patients. Brief Article Aug 31, 2004 257
Bevacizumab can slow metastatic kidney cancer; no rise in overall survival. Evans, Jeff Oct 1, 2003 301
Interventional magnetic resonance image-guided percutaneous cryoablation of renal tumors. (Case Report). Harrison, R. Brent Jul 1, 2003 1122
A case of renal cell carcinoma metastatic to the nose and tongue. (Original Article). Walsh, M.A. May 1, 2003 1161
Renal Cell Carcinoma With Intravascular Lymphomatosis. Wang, Beverly Y.; Strauchen, James A.; Rabinowitz, David; Tillem, Steven M.; Unger, Pamela D. Sep 1, 2001 1774
A rare case of renal cell carcinoma metastatic to the sinonasal area. Hood Keng, Christopher Goh Jul 1, 2001 2462
Bilateral Renal Oncocytosis With Renal Failure. Leroy, Xavier; Lemaitre, Laurent; De La Taille, Alexandre; Hazzan, Marc; Delepaul, Bruno; Couturier, May 1, 2001 1373
Hepatic Mass in a Patient With Renal Cell Carcinoma. Pantanowitz, Liron; Saldinger, Pierre F.; Kadin, Marshall E. Apr 1, 2001 1645
Prostaglandin D synthase does not produce prostate-specific antigen cross-reactivity in renal cell carcinoma. Bulmer, Bronwyn; Ward, Greg; Diamandis, Eleftherios; Nicol, David; Clements, Judith Letter to the editor Mar 1, 2001 932
A Review of Articles from Last Month's Archives of Pathology & Laboratory Medicine. Jan 1, 2001 246
Sarcomatoid Renal Cell Carcinoma of Papillary Origin: A Case Report and Cytogenetic Evaluation. Cohen, Ronald J.; McNeal, John E.; Susman, Marleen; Sellner, Loryn N.; Iacopetta, Barry J.; Weinstei Dec 1, 2000 1974
Laryngeal Metastasis 7 Years After Radical Nephrectomy. Dee, Simpson L.; Eshghi, Majid; Otto, Clifton S. Dec 1, 2000 976
Myospherulosis in Renal Cell Carcinoma. Chau, Kai Y.; Pretorius, Janli M.; Stewart, Alistair W. Oct 1, 2000 2671
Beta-blockers and diuretics in antihypertensive therapy: the debate continues. Messerli, Franz H. Oct 1, 2000 1281
Blood-cell transplants slow kidney cancer. Seppa, N. Brief Article Sep 16, 2000 635

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters